Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 152

1.

Association between elevated visfatin and carotid atherosclerosis in patients with chronic kidney disease.

Tang X, Chen M, Zhang W.

Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2013 Jun;38(6):553-9. doi: 10.3969/j.issn.1672-7347.2013.06.002.

2.

Fibroblast Growth Factor-23 and Carotid Artery Intima Media Thickness in Chronic Kidney Disease.

Yilmaz G, Ustundag S, Temizoz O, Sut N, Demir M, Ermis V, Sevinc C, Ustundag A.

Clin Lab. 2015;61(8):1061-70.

PMID:
26427152
3.

Vitamin D deficiency, CD4+CD28null cells and accelerated atherosclerosis in chronic kidney disease.

Yadav AK, Banerjee D, Lal A, Jha V.

Nephrology (Carlton). 2012 Aug;17(6):575-81. doi: 10.1111/j.1440-1797.2012.01611.x.

PMID:
22489804
4.

Serum omentin-1, inflammation and carotid atherosclerosis in patients with non-diabetic chronic kidney disease.

Sengul E, Duygulu G, Dindar S, Bunul F.

Ren Fail. 2013 Sep;35(8):1089-93. doi: 10.3109/0886022X.2013.817256. Epub 2013 Jul 25.

PMID:
23883412
5.

Atherosclerosis is associated with plasminogen activator inhibitor type-1 in chronic haemodialysis patients.

Peng Y, Liu H, Liu F, Ouyang L, Cheng M, Gao L, Pan F, Liu Y, Chen X, Li J.

Nephrology (Carlton). 2008 Oct;13(7):579-86. doi: 10.1111/j.1440-1797.2008.00987.x.

PMID:
19161364
6.

[Relationship between serum free fatty acid and cytokines, carotid atherosclerosis in chronic kidney disease].

Wu BB, Zhang LM, Mei CL, Tang Q, Lu YZ.

Zhonghua Nei Ke Za Zhi. 2010 Jul;49(7):572-6. Chinese.

PMID:
20979766
7.

[Increased levels of advanced oxidation protein products are associated with atherosclerosis in chronic kidney disease].

Yang XB, Hou FF, Wu Q, Zhou H, Liu ZR, Yang Y, Zhang X.

Zhonghua Nei Ke Za Zhi. 2005 May;44(5):342-6. Chinese.

PMID:
16009002
8.

Level of asymmetric dimethylarginine and carotid atherosclerosis in patients with chronic kidney disease.

Zhang WR, Hou FF, Ning JP, Yang XB, Wu Q, Tao LJ, Chen BM, Li HY, Chang L.

Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2006 Oct;31(5):621-8.

9.

Cytotoxic CD4+CD28 null T lymphocytes, systemic inflammation and atherosclerotic risk in patients with chronic kidney disease.

Yadav AK, Lal A, Jha V.

Nephron Clin Pract. 2012;120(4):c185-93. doi: 10.1159/000338352. Epub 2012 Aug 16.

PMID:
22907478
10.

Visfatin (nampt) and ghrelin as novel markers of carotid atherosclerosis in patients with type 2 diabetes.

Kadoglou NP, Sailer N, Moumtzouoglou A, Kapelouzou A, Tsanikidis H, Vitta I, Karkos C, Karayannacos PE, Gerasimidis T, Liapis CD.

Exp Clin Endocrinol Diabetes. 2010 Feb;118(2):75-80. doi: 10.1055/s-0029-1237360. Epub 2009 Oct 15.

PMID:
19834878
11.

Increased serum visfatin in patients with metabolic syndrome and carotid atherosclerosis.

Zhong M, Tan HW, Gong HP, Wang SF, Zhang Y, Zhang W.

Clin Endocrinol (Oxf). 2008 Dec;69(6):878-84. doi: 10.1111/j.1365-2265.2008.03248.x. Epub 2008 Mar 20.

PMID:
18363885
12.

Interleukin-2 levels are associated with carotid artery intima-media thickness.

Elkind MS, Rundek T, Sciacca RR, Ramas R, Chen HJ, Boden-Albala B, Rabbani L, Sacco RL.

Atherosclerosis. 2005 May;180(1):181-7. Epub 2005 Jan 8.

PMID:
15823291
14.

[Hyperhomocysteinemia, oxidative stress and microinflammation in chronic renal failure: their roles in atherogene].

Yu YM, Hou FF, Zhang X, Zhou H, Liu ZQ.

Zhonghua Nei Ke Za Zhi. 2004 Apr;43(4):292-5. Chinese.

PMID:
15130417
15.

Undercarboxylated osteocalcin as a biomarker of subclinical atherosclerosis in non-dialysis patients with chronic kidney disease.

Zhang M, Ni Z, Zhou W, Qian J.

J Biomed Sci. 2015 Sep 17;22:75. doi: 10.1186/s12929-015-0183-6.

16.

Association between visfatin levels and coronary artery disease in patients with chronic kidney disease.

Lu YC, Hsu CC, Yu TH, Wang CP, Lu LF, Hung WC, Chiu CA, Chung FM, Lee YJ, Tsai IT.

Iran J Kidney Dis. 2013 Nov;7(6):446-52.

17.

Serum fibroblast growth factor-21 levels are associated with carotid atherosclerosis independent of established cardiovascular risk factors.

Chow WS, Xu A, Woo YC, Tso AW, Cheung SC, Fong CH, Tse HF, Chau MT, Cheung BM, Lam KS.

Arterioscler Thromb Vasc Biol. 2013 Oct;33(10):2454-9. doi: 10.1161/ATVBAHA.113.301599. Epub 2013 Jul 25.

18.

Effects of atorvastatin on apelin, visfatin (nampt), ghrelin and early carotid atherosclerosis in patients with type 2 diabetes.

Kadoglou NP, Sailer N, Kapelouzou A, Lampropoulos S, Vitta I, Kostakis A, Liapis CD.

Acta Diabetol. 2012 Aug;49(4):269-76. doi: 10.1007/s00592-011-0310-0. Epub 2011 Jul 12.

PMID:
21748474
19.

Circulating matrix metalloproteinase-2 is an independent correlate of proteinuria in patients with chronic kidney disease.

Nagano M, Fukami K, Yamagishi S, Ueda S, Kaida Y, Matsumoto T, Yoshimura J, Hazama T, Takamiya Y, Kusumoto T, Gohara S, Tanaka H, Adachi H, Okuda S.

Am J Nephrol. 2009;29(2):109-15. doi: 10.1159/000151439. Epub 2008 Aug 14.

PMID:
18701818
20.

Endothelial dysfunction, inflammation and atherosclerosis in chronic kidney disease--a cross-sectional study of predialysis, dialysis and kidney-transplantation patients.

Recio-Mayoral A, Banerjee D, Streather C, Kaski JC.

Atherosclerosis. 2011 Jun;216(2):446-51. doi: 10.1016/j.atherosclerosis.2011.02.017. Epub 2011 Feb 18.

PMID:
21414625

Supplemental Content

Support Center